These findings indicated that sorafenib sensitivity is possibly related to the activation of ERK and autophagy signaling pathways in HCC cells; hence, measurement of basal FGL1 expression levels could be useful as a predictor of sorafenib sensitivity. The gene discussed is FGL1; the disease is hepatocellular carcinoma.